Lyme disease testing
2006; Elsevier BV; Volume: 6; Issue: 3 Linguagem: Inglês
10.1016/s1473-3099(06)70387-5
ISSN1474-4457
AutoresSteven Phillips, Joseph J. Burrascano, Richard I. Horowitz, Virginia R Savely, Raphael B. Stricker,
Tópico(s)Mosquito-borne diseases and control
ResumoIn the October 2005 issue of The Lancet Infectious Diseases, Roxanne Nelson reported 1 Nelson R Controversy brewing over Lyme disease testing. Lancet Infect Dis. 2005; 5: 605 Summary Full Text Full Text PDF Google Scholar about the unreliability of standard testing for Lyme disease. Paul Mead, an epidemiologist at the US Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA), expressed concern about newer Lyme disease assays “whose accuracy and clinical usefulness has not been adequately established”. Mead seems unconcerned that the CDC's reporting methods miss more than 90% of Lyme cases. 2 Meek JI Roberts CL Smith EV Cartter ML Underreporting of Lyme disease by Connecticut physicians, 1992. J Public Health Manag Pract. 1996; 2: 61-65 Crossref PubMed Scopus (80) Google Scholar , 3 Boltri JM Hash RB Vogel RL Patterns of Lyme disease diagnosis and treatment by family physicians in a southeastern state. J Community Health. 2002; 27: 395-402 Crossref PubMed Scopus (11) Google Scholar
Referência(s)